UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials

The Annals of thoracic surgery, 2000-08, Vol.70 (2), p.516-526

2000

Volltextzugriff (PDF)

ACQUISITION OF ENGLISH STRUCTURES: A CASE STUDY OF AN ADULT NATIVE SPEAKER OF ARABIC IN AN ENGLISH‐SPEAKING ENVIRONMENT

Language learning, 1977-06, Vol.27 (1), p.75-91

1977

Volltextzugriff (PDF)

Addictive Disorders in Cardiovascular Medicine

Addictive Disorders in Medical Populations, 2010, p.251-275

2010

Volltextzugriff (PDF)

Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension

Journal of human hypertension, 2010-06, Vol.24 (6), p.430-430

2010

Volltextzugriff (PDF)

Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension

Journal of human hypertension, 2010-01, Vol.24 (1), p.64-73

2010

Volltextzugriff (PDF)

Additivity of Nebivolol/Valsartan Single-Pill Combination Versus Other Single-Pill Combinations for Hypertension

Journal of the American Society of Hypertension, 2016-07, Vol.10, p.e5-e6

2016

Volltextzugriff (PDF)

Aliskiren, a novel orally effective renin inhibitor, provides antihypertensive efficacy and placebo-like tolerability similar to an at 1-receptor blocker in hypertensive patients

American journal of hypertension, 2004, Vol.17 (5), p.S108-S108

2004

Volltextzugriff (PDF)

Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients

Circulation (New York, N.Y.), 2005-03, Vol.111 (8), p.1012-1018

2005

Volltextzugriff (PDF)

Aliskiren Monotherapy Does Not Cause Paradoxical Blood Pressure Rises: Meta-Analysis of Data From 8 Clinical Trials

Hypertension (Dallas, Tex. 1979), 2010-01, Vol.55 (1), p.54-60

2010

Volltextzugriff (PDF)

Allergic angina and allergic myocardial infarction: a new twist on an old syndrome

Canadian journal of cardiology, 2002-05, Vol.18 (5), p.508

2002

Volltextzugriff (PDF)

Ambulatory electrocardiographic correlates of ventricular inducibility during programmed electrical stimulation

Journal of the American College of Cardiology, 1985-05, Vol.5 (5), p.1087-1093

1985

Volltextzugriff (PDF)

Angioscopy for intraoperative management of thromboembolectomy

Archives of surgery (Chicago. 1960), 1990-10, Vol.125 (10), p.1357

1990

Volltextzugriff (PDF)

Antiarrhythmic Drug Effect Assessed from Ventricular Arrhythmia Reduction in the Ambulatory Electrocardiogram and Treadmill Test: Comparison of Propranolol, Procainamide and Quinidine

Survey of anesthesiology, 1979-10, Vol.23 (5), p.283

1979

Volltextzugriff (PDF)

Antiarrhythmic drug effect assessed from ventricular arrhythmia reduction in the ambulatory electrocardiogram and treadmill test: Comparison of propranolol, procainamide and quinidine

The American journal of cardiology, 1978-09, Vol.42 (3), p.473-480

1978

Volltextzugriff (PDF)

Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult African Americans with mild to moderate hypertension

Clinical therapeutics, 2001-08, Vol.23 (8), p.1193-1208

2001

Volltextzugriff (PDF)

Antihypertensive efficacy and safety of Losartan alone and in combination with hydrochlorothiazide in adult african americans with mild to moderate hypertension

Clinical therapeutics, 2001-11, Vol.23 (11), p.1922-1922

2001

Volltextzugriff (PDF)

Assessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension

Clinical therapeutics, 1999-03, Vol.21 (3), p.442-453

1999

Volltextzugriff (PDF)

Assessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension. Eprosartan Study Group

Clinical therapeutics, 1999-03, Vol.21 (3), p.442

1999

Volltextzugriff (PDF)

AT(1)-receptor blockers: differences that matter

Journal of human hypertension, 2002-08, Vol.16 Suppl 3, p.S9

Gradman, A H

2002

Volltextzugriff (PDF)

AT1-receptor blockers: differences that matter

Journal of human hypertension, 2002-08, Vol.16 (S3), p.S9-S16

Gradman, A H

2002

Volltextzugriff (PDF)

Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure : results of a multicenter trial

Circulation (New York, N.Y.), 1992-03, Vol.85 (3), p.942-949

1992

Volltextzugriff (PDF)

Blood pressure target values: the saga continues

European heart journal, 2016-03, Vol.37 (12), p.965-967

Gradman, Alan H

2016

Volltextzugriff (PDF)

A Call for Appropriate Evidence and Outcomes-Based Use and Measurement of Anticoagulation for Atrial Fibrillation: Moving the Population Towards Improved Health Via Multiple Stakeholders

Journal of managed care & specialty pharmacy, 2015-11, Vol.21 (11), p.1034-1038

2015

Volltextzugriff (PDF)

Cardiac effects of cocaine: a review

The Yale journal of biology & medicine, 1988-03, Vol.61 (2), p.137-147

Gradman, A H

1988

Volltextzugriff (PDF)

Changes in plasma renin match the antihypertensive effects of aliskiren in patients with hypertension: Placebo/irbesartan-controlled trial with the orally active renin inhibitor aliskiren

American journal of hypertension, 2005-05, Vol.18 (5), p.A234-A234

2005

Volltextzugriff (PDF)

1 – 25 von 159

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(150)
Mit Volltextzugriff
(141)

Publikationsform

Sprache

Englisch
(159)

Erscheinungsjahr

n.n

Thema

Humans
(96)
Life Sciences & Biomedicine
(90)
Science & Technology
(90)
Cardiovascular System & Cardiology
(62)
Male
(53)
Female
(50)
Hypertension
(47)
Hypertension - Drug Therapy
(47)
Middle Aged
(45)
Biological And Medical Sciences
(43)
Medical Sciences
(43)
Cardiac & Cardiovascular Systems
(37)
Aged
(33)
Antihypertensive Agents - Therapeutic Use
(30)
Peripheral Vascular Disease
(30)
Adult
(27)
Pharmacology. Drug Treatments
(27)
Blood Pressure - Drug Effects
(25)
Cardiovascular System
(25)
Drug Therapy
(25)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials

ACQUISITION OF ENGLISH STRUCTURES: A CASE STUDY OF AN ADULT NATIVE SPEAKER OF ARABIC IN AN ENGLISH‐SPEAKING ENVIRONMENT

Addictive Disorders in Cardiovascular Medicine

Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension

Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension

Additivity of Nebivolol/Valsartan Single-Pill Combination Versus Other Single-Pill Combinations for Hypertension

Aliskiren, a novel orally effective renin inhibitor, provides antihypertensive efficacy and placebo-like tolerability similar to an at 1-receptor blocker in hypertensive patients

Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients

Aliskiren Monotherapy Does Not Cause Paradoxical Blood Pressure Rises: Meta-Analysis of Data From 8 Clinical Trials

Allergic angina and allergic myocardial infarction: a new twist on an old syndrome

Ambulatory electrocardiographic correlates of ventricular inducibility during programmed electrical stimulation

Angioscopy for intraoperative management of thromboembolectomy

Antiarrhythmic Drug Effect Assessed from Ventricular Arrhythmia Reduction in the Ambulatory Electrocardiogram and Treadmill Test: Comparison of Propranolol, Procainamide and Quinidine

Antiarrhythmic drug effect assessed from ventricular arrhythmia reduction in the ambulatory electrocardiogram and treadmill test: Comparison of propranolol, procainamide and quinidine

Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult African Americans with mild to moderate hypertension

Antihypertensive efficacy and safety of Losartan alone and in combination with hydrochlorothiazide in adult african americans with mild to moderate hypertension

Assessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension

Assessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension. Eprosartan Study Group

AT(1)-receptor blockers: differences that matter

AT1-receptor blockers: differences that matter

Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure : results of a multicenter trial

Blood pressure target values: the saga continues

A Call for Appropriate Evidence and Outcomes-Based Use and Measurement of Anticoagulation for Atrial Fibrillation: Moving the Population Towards Improved Health Via Multiple Stakeholders

Cardiac effects of cocaine: a review

Changes in plasma renin match the antihypertensive effects of aliskiren in patients with hypertension: Placebo/irbesartan-controlled trial with the orally active renin inhibitor aliskiren

Suchergebnisse filtern